CEBPB-AS1

Across TCGA pan-cancer cohorts, CEBPB-AS1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of CEBPB-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CEBPB-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types CEBPB-AS1 is over-expressed in tumor, although a few such as THCA and LUAD show the opposite, repressed pattern.

THCA, LUAD, and KIRC are the cancer types where CEBPB-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEBPB-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−1.084	<.001	11	view →
LUAD	All	III,IV	−0.804	<.001	9	view →
KIRC	Male	All	+0.459	<.001	9	view →
BLCA	Male	IV	−1.907	<.001	8	view →
LUSC	Female	II,III,IV	−1.001	<.001	7	view →
UCEC	All	All	−1.640	<.001	6	view →
BRCA	All	All	−0.729	<.001	6	view →
LIHC	All	All	+0.244	<.001	5	view →
CHOL	All	All	+0.485	.008	4	view →
PRAD	All	All	−0.417	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

CEBPB-AS1–THCA

Open the THCA breakdown →